Thursday 30 August 2018

Reuters Health Report: Bayer's hemophilia A drug gets FDA approval

Reuters.com Newsletter

Bayer's hemophilia A drug gets FDA approval

The U.S. Food and Drug Administration on Thursday approved Bayer AG's drug for the treatment of hemophilia A, a rare genetic disorder in which the blood does not clot normally, the company said in a statement.

UK considers banning 'energy drink' sales to children in England

The sale of high-caffeine soft drinks to children could be banned in England, the British government said on Thursday, citing public health concerns.

FDA warns of serious genital infection linked to certain diabetes drugs

The U.S. Food and Drug Administration (FDA) said on Wednesday a serious genital infection has been reported in patients taking a certain class of diabetes drugs, with one death and 11 others hospitalized.

Vaccine tied to drop in HPV cases still not reaching half of U.S. kids

(Reuters Health) - Although a vaccine for the cancer-causing human papillomavirus (HPV) has led to a dramatic decrease in infections, a new study suggests that half of U.S. teens are still not fully vaccinated against this virus.

Pot-smoking mothers may have THC in breast milk for days

(Reuters Health) - Low levels of chemicals in marijuana like THC (tetrahydrocannabinol) can linger in breast milk for up to six days after nursing mothers use the drug, a U.S. study suggests.

Obamacare tied to fewer uninsured hospitalizations for heart disease, cancer

(Reuters Health) - With increased access to insurance under the Affordable Care Act (ACA), known as Obamacare, fewer uninsured patients have been hospitalized for serious heart conditions, a U.S. study suggests.

Scientists unpick how cannabis component may fight psychosis

British scientists have unraveled how a non-intoxicating component of cannabis acts in key brain areas to reduce abnormal activity in patients at risk of psychosis, suggesting the ingredient could become a novel anti-psychotic medicine.

Doctors may not follow peanut guidelines for allergy-prone babies

(Reuters Health) - Primary care physicians and pediatricians may not be following current guidelines that recommend introducing puréed peanuts to allergy-prone babies before the age of 6 months, a Canadian study suggests.

U.S. deaths from self-injury surpass those from diabetes

(Reuters Health) - More people in the U.S. are dying from self-inflicted harm, including suicide and drug overdose, than from diabetes, a new study suggests.

Florida finds atypical mad cow case, no human threat seen

A 6-year-old beef cow in Florida tested positive for bovine spongiform encephalopathy (BSE), commonly known as mad cow disease, the U.S. Department of Agriculture said on Wednesday.

Israel's Together to buy control of German cannabis customer

Together Pharma, which produces medical cannabis, said on Wednesday it had signed a deal to buy a controlling 50.01 percent stake in an unnamed German company, which is one of its customers, for 2 million euros.

Related Videos

R-E-S-P-E-C-T: Fans pay their last to Aretha Franklin

Netflix is at Venice Film Fest after Cannes snub

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS